Research programme: G protein-coupled receptor modulators - Ogeda

Drug Profile

Research programme: G protein-coupled receptor modulators - Ogeda

Alternative Names: ESN-401; ESN-502; ESN-601; ESN-603; ESN-700

Latest Information Update: 28 Sep 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Euroscreen
  • Developer Euroscreen; Ogeda
  • Class Small molecules
  • Mechanism of Action G protein-coupled receptor modulators; G-protein coupled receptor 43 modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Research Rheumatoid arthritis; Ulcerative colitis
  • No development reported Alzheimer's disease; Amyotrophic lateral sclerosis; Brain injuries; Inflammation; Multiple sclerosis; Obesity; Parkinson's disease; Type 2 diabetes mellitus

Most Recent Events

  • 28 Sep 2018 No recent reports of development identified for preclinical development in Alzheimer's-disease in Belgium
  • 28 Sep 2018 No recent reports of development identified for preclinical development in Amyotrophic-lateral-sclerosis in Belgium
  • 28 Sep 2018 No recent reports of development identified for preclinical development in Brain injuries in Belgium
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top